RCMI Coordinating Center (RCMI CC) Header Logo

Mandip S. Sachdeva

TitleDr.
Faculty RankProfessor
InstitutionFlorida A&M University
DepartmentCollege of Pharmacy and Pharmaceutical Sciences, Institute of Public Health
AddressFlorida A&M University
1415 S Martin Luther King Jr Blvd
Tallahassee FL 32307
Phone8505612790
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    S11AR047455     (SACHDEVA, MANDIP SINGH)Sep 1, 2001 - May 31, 2009
    NIH
    Development of Topical Neuroinflammatory Inhibitors
    Role: Principal Investigator
    SC1CA161676     (SACHDEVA, MANDIP SINGH)Sep 1, 2011 - Aug 31, 2017
    NIH
    Targeted Nanocarriers for Treatment of Lung Cancer
    Role: Principal Investigator
    R21CA175618     (SACHDEVA, MANDIP SINGH)Apr 1, 2014 - Mar 31, 2019
    NIH
    Role of Telmisartan on Intra-Tumoral Distribution of Targeted Nanoparticles
    Role: Principal Investigator
    R16GM149462     (SACHDEVA, MANDIP SINGH)Apr 1, 2023 - Mar 31, 2027
    NIH
    Exosomal Based micro RNA delivery for Resistant Lung Cancer
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Aare M, Padakanti SC, Singh M. In Vivo Pharmacodynamic and Pharmacokinetic Assessment of Cannabidiol-loaded Camel Milk Exosomes in Doxorubicin-resistant Triple-negative Breast Cancer Xenografts. AAPS PharmSciTech. 2025 Sep 11; 26(7):227. PMID: 40936044.
      Citations:    Fields:    Translation:HumansAnimalsCells
    2. Aare M, Lazarte JMS, Muthu M, Rishi AK, Singh M. Genetically bio-engineered PD-L1 targeted exosomes for immunotherapy of resistant triple negative breast cancer. Drug Deliv Transl Res. 2026 Feb; 16(2):693-710. PMID: 40762902.
      Citations:    Fields:    
    3. Nathani A, Sun L, Li Y, Lazarte J, Aare M, Singh M. Targeting EGFR-TKI resistance in lung cancer: Role of miR-5193/miR-149-5p loaded NK-EVs and Carboplatin combination. Int J Pharm. 2025 Apr 30; 675:125573. PMID: 40204039.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    4. Nathani A, Khan I, Tanimoto MH, Mej?a JAA, DE Miranda AM, Rishi A, Dev S, Bastos JK, Singh M. Antitumor Potential of Guttiferone E Combined With Carboplatin Against Osimertinib-resistant H1975 Lung Cancer Through Apoptosis. Anticancer Res. 2024 Oct; 44(10):4175-4188. PMID: 39348999.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    5. Kaur S, Nathani A, Singh M. Exosomal delivery of cannabinoids against cancer. Cancer Lett. 2023 07 10; 566:216243. PMID: 37257632.
      Citations: 11     Fields:    Translation:Humans
    6. Bagde A, Dev S, Madhavi K Sriram L, Spencer SD, Kalvala A, Nathani A, Salau O, Mosley-Kellum K, Dalvaigari H, Rajaraman S, Kundu A, Singh M. Biphasic burst and sustained transdermal delivery in vivo using an AI-optimized 3D-printed MN patch. Int J Pharm. 2023 Apr 05; 636:122647. PMID: 36754185.
      Citations: 13     Fields:    Translation:HumansAnimals
    7. Kalvala AK, Nimma R, Bagde A, Surapaneni SK, Patel N, Arthur P, Sun L, Singh R, Kommineni N, Nathani A, Li Y, Singh M. The role of Cannabidiol and tetrahydrocannabivarin to overcome doxorubicin resistance in MDA-MB-231 xenografts in athymic nude mice. Biochimie. 2023 May; 208:19-30. PMID: 36535544.
      Citations: 12     Fields:    Translation:HumansAnimals
    8. Arthur P, Kandoi S, Sun L, Kalvala A, Kutlehria S, Bhattacharya S, Kulkarni T, Nimma R, Li Y, Lamba DA, Singh M. Biophysical, Molecular and Proteomic Profiling of Human Retinal Organoid-Derived Exosomes. Pharm Res. 2023 Apr; 40(4):801-816. PMID: 36002615.
      Citations: 20     Fields:    Translation:HumansCells
    9. Kumar Kalvala A, Bagde A, Arthur P, Kumar Surapaneni S, Ramesh N, Nathani A, Singh M. Role of Cannabidiol and Tetrahydrocannabivarin on Paclitaxel-induced neuropathic pain in rodents. Int Immunopharmacol. 2022 Jun; 107:108693. PMID: 35303507.
      Citations: 17     Fields:    Translation:Animals
    10. Kutlehria S, Sachdeva MS. Role of In Vitro Models for Development of Ophthalmic Delivery Systems. Crit Rev Ther Drug Carrier Syst. 2021; 38(3):1-31. PMID: 34348017.
      Citations: 8     Fields:    
    11. Gebeyehu A, Kommineni N, Meckes DG, Sachdeva MS. Role of Exosomes for Delivery of Chemotherapeutic Drugs. Crit Rev Ther Drug Carrier Syst. 2021; 38(5):53-97. PMID: 34375513.
      Citations: 37     Fields:    Translation:Cells
    12. Kommineni N, Nottingham E, Bagde A, Patel N, Rishi AK, Dev SRS, Singh M. Role of nano-lipid formulation of CARP-1 mimetic, CFM-4.17 to improve systemic exposure and response in osimertinib resistant non-small cell lung cancer. Eur J Pharm Biopharm. 2021 Jan; 158:172-184. PMID: 33220423.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    13. Pandi P, Bulusu R, Kommineni N, Khan W, Singh M. Amorphous solid dispersions: An update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products. Int J Pharm. 2020 Aug 30; 586:119560. PMID: 32565285.
      Citations: 92     Fields:    Translation:HumansAnimals
    14. Kutlehria S, Bagde A, Patel N, Singh M. Whole-Eye Perfusion Model for Screening of the Ocular Formulations via Confocal Laser Scanning Microscopy. AAPS PharmSciTech. 2019 Sep 12; 20(7):307. PMID: 31515645.
      Citations: 1     Fields:    Translation:Animals
    15. Patel K, Doddapaneni R, Patki M, Sekar V, Bagde A, Singh M. Erlotinib-Valproic Acid Liquisolid Formulation: Evaluating Oral Bioavailability and Cytotoxicity in Erlotinib-Resistant Non-small Cell Lung Cancer Cells. AAPS PharmSciTech. 2019 Mar 04; 20(3):135. PMID: 30830506.
      Citations: 8     Fields:    Translation:HumansAnimalsCells
    16. Andey T, Bora-Singhal N, Chellappan SP, Singh M. Cationic lipoplexes for treatment of cancer stem cell-derived murine lung tumors. Nanomedicine. 2019 06; 18:31-43. PMID: 30831275.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    17. Chowdhury N, Vhora I, Patel K, Bagde A, Kutlehria S, Singh M. Development of Hot Melt Extruded Solid Dispersion of Tamoxifen Citrate and Resveratrol for Synergistic Effects on Breast Cancer Cells. AAPS PharmSciTech. 2018 Oct; 19(7):3287-3297. PMID: 30218267.
      Citations: 10     Fields:    Translation:HumansAnimalsCells
    18. Kutlehria S, Vhora I, Bagde A, Chowdhury N, Behl G, Patel K, Singh M. Tacrolimus Loaded PEG-Cholecalciferol Based Micelles for Treatment of Ocular Inflammation. Pharm Res. 2018 Apr 16; 35(6):117. PMID: 29663141.
      Citations: 7     Fields:    Translation:HumansAnimals
    19. Doddapaneni R, Patel K, Chowdhury N, Singh M. Reversal of drug-resistance by noscapine chemo-sensitization in docetaxel resistant triple negative breast cancer. Sci Rep. 2017 Nov 20; 7(1):15824. PMID: 29158480.
      Citations: 17     Fields:    Translation:HumansAnimalsCells
    20. Kutlehria S, Behl G, Patel K, Doddapaneni R, Vhora I, Chowdhury N, Bagde A, Singh M. Cholecalciferol-PEG Conjugate?Based Nanomicelles of Doxorubicin for Treatment of Triple-Negative Breast Cancer. AAPS PharmSciTech. 2018 Feb; 19(2):792-802. PMID: 29019073.
      Citations: 10     Fields:    Translation:HumansCells
    21. Chowdhury N, Vhora I, Patel K, Doddapaneni R, Mondal A, Singh M. Liposomes co-Loaded with 6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3 (PFKFB3) shRNA Plasmid and Docetaxel for the Treatment of non-small Cell Lung Cancer. Pharm Res. 2017 Nov; 34(11):2371-2384. PMID: 28875330.
      Citations: 19     Fields:    Translation:HumansAnimalsCells
    22. Doddapaneni R, Patel K, Chowdhury N, Singh M. Noscapine chemosensitization enhances docetaxel anticancer activity and nanocarrier uptake in triple negative breast cancer. Exp Cell Res. 2016 08 01; 346(1):65-73. PMID: 27177833.
      Citations: 15     Fields:    Translation:HumansAnimalsCells
    23. Patel K, Chowdhury N, Doddapaneni R, Boakye CHA, Godugu C, Singh M. Piperlongumine for Enhancing Oral Bioavailability and Cytotoxicity of Docetaxel in Triple-Negative Breast Cancer. J Pharm Sci. 2015 Dec; 104(12):4417-4426. PMID: 26372815.
      Citations: 31     Fields:    Translation:HumansAnimalsCells
    24. Godugu C, Doddapaneni R, Patel AR, Singh R, Mercer R, Singh M. Novel Gefitinib Formulation with Improved Oral Bioavailability in Treatment of A431 Skin Carcinoma. Pharm Res. 2016 Jan; 33(1):137-54. PMID: 26286185.
      Citations: 13     Fields:    Translation:HumansAnimalsCells
    25. Patel AR, Chougule MB, Lim E, Francis KP, Safe S, Singh M. Theranostic tumor homing nanocarriers for the treatment of lung cancer. Nanomedicine. 2014 Jul; 10(5):1053-63. PMID: 24355163.
      Citations: 7     Fields:    Translation:HumansAnimals
    26. Singh M, Ferdous AJ, Kanikkannan N, Faulkner G. Stealth monensin immunoliposomes as potentiator of immunotoxins in vitro. Eur J Pharm Biopharm. 2001 Jul; 52(1):13-20. PMID: 11438419.
      Citations: 1     Fields:    Translation:HumansAnimalsCells
    Sachdeva's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (155)
    Explore
    _
    Co-Authors (2)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

    For technical support please contact support